Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 1/20 | 0.33 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.33 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10169614 | 0.92 | CYP1A2 (0.31) | CYP1A2CYP2D6CYP2C19 | |
| SCHEMBL10911395 | 0.85 | — | — | |
| SCHEMBL10911397 | 0.85 | — | — | |
| SCHEMBL11328512 | 0.84 | — | — | |
| SCHEMBL19205997 | 0.81 | — | — | |
| SCHEMBL19205999 | 0.81 | — | — | |
| SCHEMBL20624694 | 0.81 | — | — | |
| SCHEMBL10304159 | 0.81 | SMN1; SMN2 (0.32) | — | |
| SCHEMBL17528454 | 0.81 | — | — | |
| SCHEMBL23254933 | 0.81 | SIGMAR1 (0.33) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20170233365-A1 | CYCLOOCTENES FOR BIOORTHOGONOL REACTIONS | THE GENERAL HOSPITAL CORPORATION | 2017-08-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170233365-A1 | CYCLOOCTENES FOR BIOORTHOGONOL REACTIONS | SQLE, BBOX1, TKT | CYP1A2 119/4885CYP2D6 93/4885CYP2C19 215/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.